C

Carmine Therapeutics

32 employees

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Basic info

Industry

biotechnology research

Sectors

Rare diseases
Biotechnology
Health Care
Red blood cell extracellular vesicles
Biotech
Therapeutics
Pharmaceutical
Non-viral gene therapy
Platform technologies

Date founded

2019

Funding rounds raised

Total raised

$3.4M

from 2 investors over 2 rounds

C

Carmine Therapeutics raised undisclosed on October 13, 2022

Investors: 华盖资本有限责任公司

C

Carmine Therapeutics raised $3.4M on August 29, 2019

Investors: Esco Ventures X

FAQ